HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Reaction

Dihydrocholesterol → 3beta-(Prop-2-ynyloxy)cholestanol

HRID 74836
Notes
Print preview

Reaction equation

HRID 74836 reaction equation
[CH3:1][C@@H:2]([C@@H:9]1[C@@:13]2([CH3:28])[CH2:14][CH2:15][C@@H:16]3[C@@:21]4([CH3:27])[CH2:22][CH2:23][C@H:24]([OH:26])[CH2:25][C@@H:20]4[CH2:19][CH2:18][C@H:17]3[C@@H:12]2[CH2:11][CH2:10]1)[CH2:3][CH2:4][CH2:5][CH:6]([CH3:8])[CH3:7].CC(C)([O-:32])C.[K+].[CH2:35](Br)[C:36]#[CH:37]>C1(C)C=CC=CC=1.CCCCCC.CCOC(C)=O>[CH2:35]([O:26][C@H:24]1[CH2:23][CH2:22][C@@:21]2([CH3:27])[CH:20]([CH2:19][CH2:18][C@@H:17]3[C@@H:16]2[CH2:15][CH2:14][C@@:13]2([CH3:28])[C@H:12]3[CH2:11][CH2:10][C@@H:9]2[C@H:2]([CH3:1])[CH2:3][CH2:4][CH2:5][CH:6]([CH3:7])[CH2:8][OH:32])[CH2:25]1)[C:36]#[CH:37]
ParticipantsProcedureWorkupSources & evidenceReaction notes

Participants

7

Reactant 3

HCID 6665DihydrocholesterolHCID 7842Propargyl bromideHCID 23665647Potassium tert-butoxide

Product 1

HCID 866582823beta-(Prop-2-ynyloxy)cholestanol

Reagents, catalysts & solvents 3

HCID 1140TolueneSolventHCID 8058
Hexane
Solvent
HCID 8857Ethyl AcetateSolvent

Procedure

3β-cholestanol (1.23 g, 3.16 mmol) was completely dissolved in anhydrous toluene (7 mL, 0.45 M) at r.t. Powdered potassium t-butoxide (1.06 g, 9.49 mmol, 3 eq) was added in one portion. The mixture was stirred at r.t. for 3 h. A solution of propargyl bromide (80 wt % in toluene, 0.94 g, 6.32 mmol, 2 eq) was added. The mixture was stirred at r.t. for 3 days. The mixture was diluted with hexane (30 mL) and EtOAc (10 mL), washed with water (2×60 mL) and brine (60 mL). The aqueous phase was extracted once with EtOAc (20 mL). The combined organic phases were dried (Na2SO4), filtered and the filtrate was evaporated onto silica gel and purified by column chromatography (silica gel 2.5×24 cm, gradient elution with hexane 250 mL, hexane-EtOAc 125:5) to give the product as a yellow solid. Recrystallization from EtOAc (3 mL) gave off-white crystals (736 mg, 55%). 1H NMR (CDCl3, 400 MHz) δ 4.18 (d, 2H, J=2.2), 3.45 (m, 1H), 2.38 (t, 1H, J=2.2), 1.99-0.57 (m, 31H), 0.89 (d, 3H, J=6.6), 0.86 (d, 3H, J=6.6), 0.86 (d, 3H, J=6.6), 0.79 (s, 3H), 0.64 (s, 3H).

Workup

  1. stirringThe mixture was stirred at r.t. for 3 days
  2. washwashed with water (2×60 mL) and brine (60 mL)
  3. extractionThe aqueous phase was extracted once with EtOAc (20 mL)
  4. dry with materialThe combined organic phases were dried (Na2SO4)
  5. filtrationfiltered
  6. customthe filtrate was evaporated onto silica gel
  7. custompurified by column chromatography (silica gel 2.5×24 cm, gradient elution with hexane 250 mL, hexane-EtOAc 125:5)

Sources & evidence

ORD record
ord-217acad05b48403ebec4ecfc19a402bd
Source dataset
uspto-grants-2014_09
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US08828952B2

Reaction notes

Loading…

On this pageParticipantsProcedureWorkupSources & evidenceReaction notes